Schonfeld Strategic Advisors LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 74 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,108,000
-17.4%
289,179
+13.6%
0.02%
-18.5%
Q2 2021$2,551,000
-35.7%
254,603
-38.8%
0.03%
-43.8%
Q1 2021$3,970,000
+814.7%
415,692
+748.9%
0.05%
+500.0%
Q3 2020$434,00048,9700.01%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$7,605,0001.52%
Privium Fund Management (UK) Ltd 48,470$353,0000.38%
Pentwater Capital Management LP 4,967,227$36,211,0000.37%
J. Goldman & Co LP 301,391$2,197,0000.11%
Perceptive Advisors 787,745$5,743,0000.08%
KNOTT DAVID M 29,566$216,0000.08%
Virtus ETF Advisers LLC 23,082$168,0000.07%
Altium Capital Management LP 32,238$235,0000.06%
Advisory Services Network, LLC 268,290$1,956,0000.06%
MCF Advisors LLC 66,185$482,0000.05%
View complete list of POSEIDA THERAPEUTICS INC shareholders